Delivery Order SPE2DB20D1004-SPE2DB24FG3W6

Award Date 7/3/24
Potential Completion Date 7/5/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,424.29, is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,917.88, is for the delivery of valsartan-HCTZ 160-12.5 mg tablets over the period from April 2025 to April 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,493.49, is for the delivery of VALSARTAN-HCTZ 160-12.5 MG tablets in 90-count packages. The contract has an ultimate completion date of November 20, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,018.59 firm-fixed-price delivery order is for the supply of Valsartan-HCTZ 320-25 mg tablets in 90-count bottles. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp's Corporate Office Division a $4,590.37 firm-fixed-price delivery order contract (SPE2DX15D3108|SPE2DX24F27HA) for the supply of 90-count valsartan-hydrochlorothiazide 80-12.5 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical and...
The U.S. Defense Logistics Agency (DLA) awarded a $6,894.05 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,062,501 units of Valsartan-HCTZ 320-12.5 mg tablets. The contract has an ultimate completion date of January 29, 2025. This contract is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,193.44, is for the delivery of valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. This is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,868.36 firm fixed-price delivery order is for the supply of 90 tablets of the medication Valsartan-HCTZ 160-12.5 mg. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 2025. This single-award IDC enables...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,985.62, is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 7, 2025. It is not associated with any set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,543.10, is for the supply of 4564840878 - Valsartan-HCTZ 320-25 mg tablet, 90s. The contract has an ultimate completion date of June 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FG3W6
    Delivery Order

This contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a delivery order with a ceiling value of $1,474.58 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages, with a performance period through July 2024. This award falls under the DLA's broader IDC with Amerisourcebergen, valued at $999,999,999, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. As a major pharmaceutical distributor and healthcare solutions provider, Amerisourcebergen plays a critical role in supplying medical products to federal government agencies, including the DLA and Department of Justice.

Generated 2/27/25, 10:33 AM